A Study to Investigate the Safety and Efficacy of TEG002 in Relapsed/Refractory Multiple Myeloma Patients
Clinical trial NCT04688853 · UNKNOWN
Trial details
- NCT number
- NCT04688853
- Sponsor
- Gadeta B.V.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-13
- Primary completion
- 2023-07-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.